Skip to main content
. Author manuscript; available in PMC: 2023 May 29.
Published in final edited form as: Womens Health Issues. 2020 Jul 14;30(5):366–373. doi: 10.1016/j.whi.2020.06.003

Table 3.

Treatment Characteristics and Treatment Preferences and their Associations with VHA Psychotherapy Utilization and Retention among Women Veterans Diagnosed with PTSD

Any Utilization N=986 Retention n=729
Variable n % AOR [95% CI] IRR [95% CI]

Outpatient MH care outside
VHA
 No (ref) 853 86.5%
 Yes 133 13.5% 1.42 [0.90, 2.26] 0.95 [0.75, 1.20]
Pharmacotherapy for PTSD
 No (ref) 260 26.4%
 Yes 726 73.6% 0.95 [0.57, 1.60] 1.06 [0.74, 1.52]
Gender-related preferences*
 None met (ref) 247 33.1%
 Any preference met 396 42.0% 1.03 [0.61, 1.72] 1.69** [1.36, 2.12]
 Both provider and setting preferences met 240 25.4% 0.80 [0.49, 1.31] 2.18** [1.66, 2.86]
Group-related preferences
 Do not prefer groups (ref) 211 29.0%
 Groups acceptable 516 71.0% 1.06 [0.74, 1.53] 2.22** [1.85, 2.67]

Note. *Excludes 44 women with neither preference; PTSD = Posttraumatic Stress Disorder; MH = mental health; VHA = Veterans Health Administration; ref = reference group; AOR = adjusted odds ratio; IIR = incidence rate ratio; CI = confidence interval; Odds ratios and rate ratios are adjusted for race, parenting status, comorbid psychiatric diagnoses, and military sexual trauma; odds ratios and incidence rate ratios for non-VA MH care and pharmacotherapy are each adjusted for the other; odds ratios and incidence rate ratios for gender-related preferences and group-related preferences are also each adjusted for the other; missing values possible on each variable.

*

p < .05

**

p < .01